PMC:7253235 / 1876-2055 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"76","span":{"begin":29,"end":35},"obj":"Disease"},{"id":"77","span":{"begin":94,"end":103},"obj":"Disease"},{"id":"78","span":{"begin":110,"end":124},"obj":"Disease"}],"attributes":[{"id":"A76","pred":"tao:has_database_id","subj":"76","obj":"MESH:D009369"},{"id":"A77","pred":"tao:has_database_id","subj":"77","obj":"MESH:D007239"},{"id":"A78","pred":"tao:has_database_id","subj":"78","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"rosis. Those undergoing anti-cancer therapy are at theoretically increased susceptibility for infection, with type of cancer not necessarily dictating outcome. A review of the lit"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T30","span":{"begin":29,"end":35},"obj":"Disease"},{"id":"T31","span":{"begin":94,"end":103},"obj":"Disease"},{"id":"T32","span":{"begin":118,"end":124},"obj":"Disease"}],"attributes":[{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"rosis. Those undergoing anti-cancer therapy are at theoretically increased susceptibility for infection, with type of cancer not necessarily dictating outcome. A review of the lit"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T4","span":{"begin":160,"end":161},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"rosis. Those undergoing anti-cancer therapy are at theoretically increased susceptibility for infection, with type of cancer not necessarily dictating outcome. A review of the lit"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T20","span":{"begin":29,"end":35},"obj":"Phenotype"},{"id":"T21","span":{"begin":75,"end":103},"obj":"Phenotype"},{"id":"T22","span":{"begin":118,"end":124},"obj":"Phenotype"}],"attributes":[{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A21","pred":"hp_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/HP_0002719"},{"id":"A22","pred":"hp_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"rosis. Those undergoing anti-cancer therapy are at theoretically increased susceptibility for infection, with type of cancer not necessarily dictating outcome. A review of the lit"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T17","span":{"begin":7,"end":159},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"rosis. Those undergoing anti-cancer therapy are at theoretically increased susceptibility for infection, with type of cancer not necessarily dictating outcome. A review of the lit"}